This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984
Title: Klaus-Dieter Bode: A Legacy of Innovation in Imidazoline Derivatives
Introduction
Klaus-Dieter Bode was a notable inventor known for his contributions to the field of chemistry, particularly in the development of imidazoline derivatives. His work has left a lasting impact on the industry, showcasing the importance of innovation in scientific research.
Latest Patents
Klaus-Dieter Bode held a patent for imidazoline derivatives, specifically focusing on compounds of the formula ##STR1## where R₁, R₂, and R₃ represent C₁-C₁₉-alkyl or C₂-C₁₉-alkenyl. This patent highlights his expertise in creating valuable chemical compounds that have various applications.
Career Highlights
Throughout his career, Klaus-Dieter Bode was associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer allowed him to collaborate with other talented professionals and contribute to significant advancements in chemical research.
Collaborations
Klaus-Dieter Bode worked alongside esteemed colleagues such as Gunther Boehmke and Wilfried Kortmann. Their collaborative efforts in research and development further enhanced the innovative capabilities of their projects.
Conclusion
Klaus-Dieter Bode's contributions to the field of chemistry, particularly through his patent on imidazoline derivatives, demonstrate the vital role of inventors in advancing scientific knowledge. His legacy continues to inspire future generations of researchers and innovators.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile